Clinical trial · Observational
Regional Central Database Recording of Chronic Myeloid Leukemia
NCT02869256CI-TRIAL-00030482LMCunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
It will be a centralized database , multicentre (6 centers) , regional, chronic myelogenous leukemia cases of registration (CML) prospectively and retrospectively.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR-ABL1 Positive | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Practices evaluation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- compliance of the management of patients with chronic myeloid leukemia compared to the guidelines
- timeFrame
- 10 years
Secondary outcomes (1)
- measure
- overall survival
- timeFrame
- 10 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * chronic myeloid leukemia Diagnosis (CML) in chronic phase , accelerated or blast * male or female patient aged 18 years or more * Cases transmitted by referring hematologist , one of the 6 participating centers after patient's oral information * Clinical record presented Concertation Meeting LMC Multidisciplinary coordinated by the Institute Bergonié Exclusion Criteria: * none
References
Publications (0)
Data not yet available
No reference posted for this study.